ARTICLE | Company News
MDxHealth sales and marketing update
May 21, 2012 7:00 AM UTC
MDxHealth launched its ConfirmMDx for Prostate Cancer in the U.S. The epigenetic laboratory-developed test (LDT) assesses the presence or absence of cancer cells in biopsy tissue, ruling out healthy m...